System and method for high resolution videoconferencing

Abstract

A system and method for high resolution video conferencing is shown and described. A transmitting station and a receiving station including video cameras or sensors, a plurality of microphones and speakers, video, audio and communication processing engines are disclosed. Video is processed and transferred through the system allowing for multiple video streams to be produced and audio is processed and transferred through the system allowing for sound to be played back with an indication of position in relation to the videoconferencing system.

1 . An MMP regulator comprising a zinc chelator and a TIMP-derived peptide.  
     
     
         2 . The regulator of  claim 1  wherein the zinc chelator is selected from the group consisting of EDTA, EGTA, DTPA, CDTA, HEDTA, NTA, IDA, PSDE, AFTA, citric acid, salicylic acid, and malic acid.  
     
     
         3 . The regulator of  claim 2  wherein the zinc chelator is IDA, PSDE, or AFTA.  
     
     
         4 . The regulator of  claim 1  wherein the zinc chelator is selected from the group consisting of SEQ ID Nos. 9 and 10.  
     
     
         5 . The regulator of  claim 1  wherein the peptide comprises SEQ ID No. 1-3.  
     
     
         6 . The regulator of  claim 4  wherein the peptide is selected from the group consisting of SEQ ID Nos. 4, 5, 6, 7, and 8.  
     
     
         7 . The regulator of  claim 1  wherein the peptide contains at least one cysteine residue.  
     
     
         8 . A method of treating chronic or acute wounds comprising administering an MMP regulator comprising a zinc chelator and a TIMP-derived peptide.  
     
     
         9 . The method of  claim 8  wherein the zinc chelator is selected from the group consisting of EDTA, EGTA, DTPA, CDTA, HEDTA, NTA, IDA, PSDE, AFTA, citric acid, salicylic acid, and malic acid.  
     
     
         10 . The method of  claim 9  wherein the zinc chelator is IDA, PSDE, or AFTA.  
     
     
         11 . The method of  claim 8  wherein the zinc chelator is selected from the group consisting of SEQ ID Nos. 9 and 10.  
     
     
         12 . The method of  claim 8  wherein the peptide comprises SEQ ID No. 1-3.  
     
     
         13 . The method of  claim 12  wherein the peptide is selected from the group consisting of SEQ ID Nos. 4, 5, 6, 7, 8 and 11.  
     
     
         14 . The method of  claim 8  wherein the peptide contains at least one cysteine residue.  
     
     
         15 . A composition comprising a pharmaceutically acceptable carrier and an MMP regulator, wherein the MMP regulator comprises a zinc chelator and a TIMP-derived peptide.  
     
     
         16 . The composition of  claim 15 , wherein the composition is in topical form.  
     
     
         17 . The composition of  claim 15 , wherein the composition is in the form of a lotion, ointment, cream, gel, stick, spray, paste, mousse, solution, dispersion, emulsion, solid, and liposome.  
     
     
         18 . The regulator of  claim 15  wherein the zinc chelator is selected from the group consisting of EDTA, EGTA, DTPA, CDTA, HEDTA, NTA, IDA, PSDE, AFTA, citric acid, salicylic acid, and malic acid.  
     
     
         19 . The regulator of  claim 18  wherein the zinc chelator is IDA, PSDE, or AFTA.  
     
     
         20 . The regulator of  claim 15  wherein the zinc chelator is selected from the group consisting of SEQ ID Nos. 9 and 10.  
     
     
         21 . The regulator of  claim 15  wherein the peptide comprises SEQ ID No. 1-3.  
     
     
         22 . The regulator of  claim 20  wherein the peptide is selected from the group consisting of SEQ ID Nos. 4, 5, 6, 7, and 8.  
     
     
         23 . The regulator of  claim 15  wherein the peptide contains at least one cysteine residue.